Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartflow, Inc. - Common Stock (NQ:HTFL)

29.39 -0.12 (-0.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Heartflow, Inc. - Common Stock

TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
Via Investor Brand Network
Topics Artificial Intelligence
The Future of Intoxication Detection May Be in Your Voice
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
From Heartflow, Inc.
Via GlobeNewswire
News headline image
The Future of Intoxication Detection May Be in Your Voice
From BioMedWire
Via GlobeNewswire
News headline image
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Heartflow Files Patent Infringement Lawsuit Against Cleerly
Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow Platform 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional Athletes
NBA legend Muggsy Bogues joins effort to detect and manage coronary artery disease in retired players using AI-powered Heartflow Analysis 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.
Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque Analysis 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD
Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National Health Service 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow Reports Third Quarter 2025 Financial Results
Initiates Full Year 2025 Revenue Guidance of $173.0 Million to $173.5 Million 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
Multicenter outcomes FISH&CHIPS study of nearly 8,000 patients confirms total plaque volume as a powerful independent predictor of long-term cardiovascular events 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025
Data to highlight the precision of AI-powered Heartflow Plaque Staging framework in predicting long-term cardiovascular outcomes 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025
From Heartflow, Inc.
Via GlobeNewswire
News headline image
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning
From Heartflow, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.